Translational regulation of TRAIL sensitivity

Area of Science:

• Molecular Biology
• Cellular Biology
• Cancer Research

Background:

• TNF-related apoptosis-inducing ligand (TRAIL) induces apoptosis in tumor cells, but sensitivity varies.
• Previous research linked TRAIL sensitivity to c-myc and MEK/Erk pathways enhancing caspase activation.

Purpose of the Study:

• To investigate the role of the Akt-mTOR pathway in regulating TRAIL sensitivity.
• To explore the Akt-mTOR pathway's influence on anti-apoptotic protein translation and TRAIL resistance.
• To discuss the therapeutic potential of targeting the Akt-mTOR pathway for cancer treatment.

Main Methods:

• The study focused on the Akt-mTOR pathway's downstream targets, including S6 kinase and eIF-4E.
• Analysis of protein translation, specifically the anti-apoptotic protein FLIP(S).
• Exploration of the linkage between Akt-mTOR signaling and TRAIL-induced apoptosis.

Main Results:

• The Akt-mTOR pathway, contrary to expectations, confers TRAIL resistance.
• Akt activation selectively enhances the translation of the anti-apoptotic protein FLIP(S) via mTOR, S6 kinase, and eIF-4E.
• This mechanism provides a novel insight into TRAIL resistance in tumors.

Conclusions:

• The Akt-mTOR pathway is a critical regulator of TRAIL sensitivity, acting independently of caspase activation pathways.
• Targeting the Akt-mTOR pathway may represent a viable therapeutic strategy to overcome TRAIL resistance in cancer.
• Understanding this pathway's role is crucial for predicting patient response to TRAIL-based therapies.